REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07675811 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-27 → 2026-07-31 3. completion date: 2028-06-30 → 2029-09-20 4. primary completion date: 2027-10-16 → 2029-05-31
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical